Hocm mpuh
-
Upload
drnilesh-parikh -
Category
Health & Medicine
-
view
1.061 -
download
0
description
Transcript of Hocm mpuh
![Page 1: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/1.jpg)
Dr. Nilesh ParikhMD,PDCC
(Card.Anaes)
Consultant Anaesthesiologist
NADIAD
Anaesthesia for HOCM patient
![Page 2: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/2.jpg)
Hypertrophic Obstructive Cardiomyopathy
Dr. Nilesh Parikh
![Page 3: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/3.jpg)
Here is a patient named Kamlaben B Patel 85 yrs. Old,having # N/F, requring DHS Surgery.pt. is a known case of HTN Since 15 yrs. and she is taking Tab Amlodepine-Atenolol combination. Patient has been investigated and diagnosed to have HOCM by 2D ECHO., how would you proceed for this case?
![Page 4: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/4.jpg)
Hypertrophic obstructive cardiomyopathy
Overview
• Background
• Pathophysiology
• Clinical picture
• Diagnosis
• Treatment
• Anesthetic consideration
4
![Page 5: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/5.jpg)
Hypertrophic Obstructive CardioMyopathy (HOCM) is a rare genetic disorder characterized by left ventricular outflow tract (LVOT) obstruction. Clinical presentation ranges from absence of symptoms to sudden death. These patients presents considerable challenges and requires maintenance of desired hemodynamic parameters and management of specific complications. Factors like Tachycardia, Hypovolemia, Vasodilation andincreased cardiac contractility leads to exacerbation of the obstruction. Decrease in venous return and SVR or increase in myocardial contractility worsens the LVOT obstruction. These patients are highly prone to arrhythmias like AF & VT Management of anesthesia in these patients poses considerable challenges for the anesthesiologist.
![Page 6: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/6.jpg)
Background
Prevalence of HCM: 1:500 to 1:1000 individuals ○ This occurrence is higher than previously thought, suggesting
a large number of affected but undiagnosed people
Men affected by almost 2:1 ratio over women
Global disease with most cases reported from USA, Canada, Western Europe, Israel, & Asia
Most common cause of SCD, age < 40 yr
Most common cause of SCD, in competitive
athletes
![Page 7: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/7.jpg)
Normal Anatomy
7
![Page 8: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/8.jpg)
Hypertophic cardiomyopathy (HOCM)
8
![Page 9: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/9.jpg)
Hypertrophic cardiomyopathy (HOCM)
9
![Page 10: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/10.jpg)
Pathophysiology of HOCM
Involves 4 interrelated processes:
– Left ventricular outflow obstruction
–Diastolic dysfunction
–Myocardial ischemia
–Mitral regurgitation
![Page 11: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/11.jpg)
Pathophysiology
• Hypertrophy: in any region of left ventricle
• SAM: systolic anterior motion of anterior MV leaflet against hypertrophic septum (Bernoulli effect)
dynamic pressure gradient across LV outflow tract
midsystolic intraventricular obstruction of the flow
• SAM - Septal Contact dynamic obstruction increased by:
afterload
preload
contractility
11
![Page 12: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/12.jpg)
• Diastolic Dysfunction
- Due to prolongation of isovolumic relaxation time (AV closure to MV opening)
- LV filling pressure
- Ventricular volume
- Atrial contribution to ventricular filling ~ 75%
• Poor Compliance
- LVEDP for any LVEDV
- CPP gradient
- Subendocardial ischemia12
Pathophysiology
![Page 13: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/13.jpg)
Symptoms:
Dyspnea on exertion (90%)
- Reduced diastolic relaxation & LV filling
Angina (70-80%) - Inadequate myocardial perfusion
Syncope (20%) - Vasovagal attack/ transient arrhythmias
Palpitation (10%) - AF
- Loss of atrial contribution in LV filling
- Rapid rate
- 50 % pts of AF manifests as systemic embolisation
![Page 14: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/14.jpg)
Hypertophic cardiomyopathy (HOCM)
• Lab studies:
– Blood test: non specific
– Genetic testing: for high risk group
• ECG:
– ST-T wave abnormalities
– LV hypertrophy, LA enlargement
– Axis deviation (left > right)
– Conduction abnormalities (P-R prolongation, BBB)
– A-fib (poor prognostic sign) 14
![Page 15: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/15.jpg)
Electrocardiogram
LV strain pattern
LBBB/ RBBB / Lt ant hemiblock
![Page 16: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/16.jpg)
ECG
![Page 17: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/17.jpg)
Hypertophic cardiomyopathy (HOCM)
• Two - Dimensional Echocardiography and Doppler
• MR and Mitral prolapse
• Flow velocity: > 4.0 m/s
• LV outflow gradient: > 50 mm Hg
• EF : high to normal
• Small LV cavity
• Left atrial enlargement
• Septal thickness: 4-6 mm thicker than normal
• The hallmarks:
– SAM of Mitral valve
– Asymmetric septal hypertrophy17
![Page 18: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/18.jpg)
X ray
Cardiomegaly
LA enlargement
Small aorta
Pulmonary edema
![Page 19: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/19.jpg)
CXRHOCM
19
Cardiac enlargement > 1/2 thoracic width
![Page 20: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/20.jpg)
Hypertophic cardiomyopathy (HOCM)
• Goals:
– Ventricular contractility
» Myocardial depression
– Ventricular volume
» Volume loading
– Ventricular compliance and outflow tract dimensions
– Pressure gradient across the LVOT
– Vasoconstriction
20
![Page 21: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/21.jpg)
Hypertophic cardiomyopathy (HOCM)
Medications
• Beta-Blockers: (Metoprolol, Propranolol, Atenolol, Sotalol )
• Calcium Channel blockers: (Verapamil)
• Antiarrhythmic: amiodarone and disopyramide
• Antitussives: avoid coughing
21
![Page 22: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/22.jpg)
Hypertophic cardiomyopathy (HOCM)
Beta - blockers
Pressure gradient across LVOT
– Inotropic state of left ventricle.
– Diastolic dysfunction
– Lt. Ventricle compliance
HR
–Myocardial oxygen consumption
–Myocardial ischemia potential
22
![Page 23: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/23.jpg)
Calcium Channel Blockers:
Verapamil
Improves symptoms and exercise capacity (patients without marked obstruction to LV outflow)
Beneficial effect on ventricular relaxation and filling
Better angina control than BB
Hemodynamic deterioration with CCB agents - lowering of the afterload in the presence of severe outflow tract gradients and high diastolic filling pressures
![Page 24: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/24.jpg)
Hypertophic cardiomyopathy (HOCM)
Antiarrhythmics
• Amiodarone (Cordarone)
To date,
Only one pharmacological agent, has been shown to reduce the incidence of arrhythmogenic sudden cardiac death
24
![Page 25: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/25.jpg)
Hypertophic cardiomyopathy (HOCM)
Contraindication
• Inotropic
• Sympathomimetic
• Nitrates
• Except in patients with CAD
• Digitalis
• Except with uncontrolled A-fib.
• Diuretics
• Preload and ventricular volume
• Outflow gradient
25
![Page 26: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/26.jpg)
Hypertophic cardiomyopathy (HOCM)
Anesthetic considerations Pre-operative period
• Pre-medication– Avoid anxiety producing tachycardia
• -blocker and/or Ca++ channel blocker– Continue untill the day of surgery and postoperative
• Avoid arrhythmia– Aggressive treatment of arrhythmia
• Antiarrhythmic Meds
• Cardioversion
• Maintain adequate intravascular volume and preload
26
![Page 27: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/27.jpg)
Hypertophic cardiomyopathy (HOCM)
Anesthetic considerations
Inhalation Anesthetics
• Negative inotropy
• Decrease SAM-Septal contact
• Ideal for dose dependant myocardial depression
(Halothane > Enflurane > Isoflurane > Desflurane, Sevoflurane)
• Avoid hypotension due to underlying hypovolemia
27
![Page 28: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/28.jpg)
Hypertophic cardiomyopathy (HOCM)
Anesthetic considerations
Regional anesthesia
• Relatively contraindicated
• Spinal should be avoided
• Epidural can be given
• Avoid bolus administration
• Avoid hypotension
• Replace intravascular volume
• Use Vasopressors like noradrenalineand phenylephrine
28
![Page 29: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/29.jpg)
Hypertophic cardiomyopathy (HOCM)
Anesthetic considerations
IV Vasopressors
• Phenylepherine /Noradrenaline
– Low risk / high yield choice for hypotension
–Augment perfusion and CPP
–Decrease pressure gradient
– Increase vagal reflex
29
![Page 30: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/30.jpg)
Hypertrophic cardiomyopathy (HOCM)
Anesthetic considerations
• MR with HOCM
Inotropes and Vasodilators worsen ventricular ejection
Vasoconstrictors improve ventricular ejection
30
![Page 31: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/31.jpg)
Here is a patient named Kamlaben B Patel 85 yrs. Old,having # N/F, requring DHS Surgery.pt. is a known case of HTN Since 15 yrs. and she is taking Tab Amlodepine-Atenolol combination. Patient has been investigated and diagnosed to have HOCM by 2D ECHO., how would you proceed for this case?
![Page 32: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/32.jpg)
![Page 33: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/33.jpg)
![Page 34: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/34.jpg)
![Page 35: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/35.jpg)
![Page 36: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/36.jpg)
![Page 37: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/37.jpg)
![Page 38: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/38.jpg)
![Page 39: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/39.jpg)
What would we the choice of Anaesthesia?
? Spinal? Epidural? General anaesthesia
![Page 40: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/40.jpg)
I planned Epidural for this patient.Pt.taken in OT. Venous access with two peripheral lines. Oxygen started and connected with monitor. First dose inj.xylocaine 2% 15 cc given. Sooner after this dose, inj. Noradrenaline infusion started @
1ml/hr.(4mg/50cc)It was incresed to 2ml/hr.as per need. (dose of Norad. is 0.04-0.4 mcg/kg/min) IV fluids inj.Hydrxyethyl starch 500 ml and one unit of Blood. Oxygen @3-4 lit/min given continuously. inj.Antibiotic, patoprazole, ondansetron given. Second dose of Epidural inj.Bupivacaine 3 cc given. Patient remained stable intra and post op. Shifed to ICU ,Where oxygen continued with monitoring. Patient’s vitals were as follow:
![Page 41: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/41.jpg)
TIME HEARTRATE
SYSTOLICBP
DIASTOLICBP
SPO2%
8:28 am 56 153 58 93
8:33 54 154 58 99
9:10 58 116 42 98
9:23 57 107 38 98
9:33 53 111 39 98
9:43 52 108 39 99
9:53 54 129 40 99
10:03 54 148 44 100
10:13 55 158 45 100
10:23 54 156 45 99
11:30 55 158 50 99
Vital parameters of patient : HOCM-DHS 10/1/2013
![Page 42: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/42.jpg)
Comments: Any patient with HTN and ECG changes always get cardiac evaluation done.
Patients with HOCM ,presenting for surgery where regional anaes. is preferred,Always maintain Hemodynamics with vasopressors and fluids. Don’t give any Inotropic or chronotropic agents.
Keep Defibrillator available ,as pts. are highly prone for Arrythmias.
Pt’s preload should be maintained adequetely.
![Page 43: Hocm mpuh](https://reader034.fdocuments.net/reader034/viewer/2022042715/5597019c1a28abf3358b4695/html5/thumbnails/43.jpg)
Thank you
spinal
EPIDURAL
G/A TAKE CARE OF ME
Message: